Balstilimab
Drug timelines are a Plus or Pro feature.
26 regulatory and trial events tracked for Balstilimab, covering 2022-10-05 to 2026-08-11. Get the full timeline:
Most recent: Clinical Trial Results: A Study of Zalifrelimab and Balstilimab for Treatment of Participants With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical) [Phase 1, Phase 2]